Proliferation and Disappearance Rates for TCM, TEM, Naive, and RA+7− CD4+ T Cells
. | Proliferation . | . | . | . | Disappearance . | . | . | . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | CCR7+ . | . | CCR7− . | . | CCR7+ . | . | CCR7− . | . | |||||||
. | CD45R0+ . | . | . | . | . | . | . | . | |||||||
Subject | p | t2 | p | t2 | d* | t1/2 | d* | t1/2 | |||||||
%/day | %/day | days | %/day | days | %/day | days | %/day | days | |||||||
C09 | 1.15 | 60 | 5.01 | 14 | 11.53 | 6.0 | 16.16 | 4.3 | |||||||
C11 | 0.74 | 94 | 7.59 | 9 | 0.00 | >c | 20.28 | 3.4 | |||||||
C12 | 1.05 | 66 | 2.27 | 31 | 0.00 | > | 8.00 | 8.7 | |||||||
C13 | 1.03 | 67 | 7.41 | 9 | 2.32 | 29.9 | 11.61 | 6.0 | |||||||
C14 | 1.00 | 69 | 2.83 | 24 | 3.20 | 21.7 | 6.56 | 10.6 | |||||||
C15 | 3.77 | 18 | 3.31 | 21 | 7.74 | 9.0 | 5.26 | 13.2 | |||||||
Mean | 1.46 | 48 | 4.74a | 15 | 4.13 | 17 | 11.31a | 6 | |||||||
± SD | ±1.14 | ±2.33 | ±4.61 | ±5.90 | |||||||||||
CD45RA+ | |||||||||||||||
C11 | 0.16 | 433 | NDb | ND | 0.00 | > | ND | ND | |||||||
C12 | 0.37 | 187 | 0.84 | 83 | 0.00 | > | 0.00 | > | |||||||
C13 | 0.11 | 630 | 2.51 | 28 | 0.00 | > | 10.35 | 6.7 | |||||||
C14 | 0.12 | 578 | 4.44 | 16 | 0.00 | > | 4.02 | 17.2 | |||||||
C15 | 0.20 | 347 | 5.56 | 12 | 0.00 | > | 8.95 | 7.7 | |||||||
Mean | 0.19 | 361 | 3.34a | 21 | 0.00 | > | 5.83a | 12 | |||||||
±SD | ±0.11 | ±2.09 | ±0.00 | ±4.74 |
. | Proliferation . | . | . | . | Disappearance . | . | . | . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | CCR7+ . | . | CCR7− . | . | CCR7+ . | . | CCR7− . | . | |||||||
. | CD45R0+ . | . | . | . | . | . | . | . | |||||||
Subject | p | t2 | p | t2 | d* | t1/2 | d* | t1/2 | |||||||
%/day | %/day | days | %/day | days | %/day | days | %/day | days | |||||||
C09 | 1.15 | 60 | 5.01 | 14 | 11.53 | 6.0 | 16.16 | 4.3 | |||||||
C11 | 0.74 | 94 | 7.59 | 9 | 0.00 | >c | 20.28 | 3.4 | |||||||
C12 | 1.05 | 66 | 2.27 | 31 | 0.00 | > | 8.00 | 8.7 | |||||||
C13 | 1.03 | 67 | 7.41 | 9 | 2.32 | 29.9 | 11.61 | 6.0 | |||||||
C14 | 1.00 | 69 | 2.83 | 24 | 3.20 | 21.7 | 6.56 | 10.6 | |||||||
C15 | 3.77 | 18 | 3.31 | 21 | 7.74 | 9.0 | 5.26 | 13.2 | |||||||
Mean | 1.46 | 48 | 4.74a | 15 | 4.13 | 17 | 11.31a | 6 | |||||||
± SD | ±1.14 | ±2.33 | ±4.61 | ±5.90 | |||||||||||
CD45RA+ | |||||||||||||||
C11 | 0.16 | 433 | NDb | ND | 0.00 | > | ND | ND | |||||||
C12 | 0.37 | 187 | 0.84 | 83 | 0.00 | > | 0.00 | > | |||||||
C13 | 0.11 | 630 | 2.51 | 28 | 0.00 | > | 10.35 | 6.7 | |||||||
C14 | 0.12 | 578 | 4.44 | 16 | 0.00 | > | 4.02 | 17.2 | |||||||
C15 | 0.20 | 347 | 5.56 | 12 | 0.00 | > | 8.95 | 7.7 | |||||||
Mean | 0.19 | 361 | 3.34a | 21 | 0.00 | > | 5.83a | 12 | |||||||
±SD | ±0.11 | ±2.09 | ±0.00 | ±4.74 |
P < 0.05 for CCR7+ versus CCR7− by paired Student's t test.
ND indicates not determined because of inadequate data for model estimate.
> indicates t2 or t1/2 exceeds maximal value detectable (p or d* close to zero).
Values for proliferation (p) and disappearance (d*) rates were derived from the best fit curves applied to the data (see Materials and Methods). t2 and t1/2 represent doubling time or half-life equivalents of p or d*, respectively; mean values for t2 and t1/2 are calculated from the mean values for p and d*, respectively.